Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Tuesday, June 24, 2025Axcelead Drug Discovery Partners Inc HQ Fujisawa Kanagawa Japan Axcelead DDP and Superluminal Medicines Inc HQ Boston Massachusetts USA Superluminal announced the intention to collaborate on drug discovery targeting specific molecular mechanisms asso...
Illuccix® Approved in U.S. for Patient Selection for Pre-Taxane RLT
Tuesday, June 24, 2025Telix today announces that the United States US Food and Drug Administration FDA has approved a label expansion for Illuccix kit for the preparation of gallium Ga gozetotide for injection to include patient selection for radioligand therapy RLT in th...
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
Tuesday, June 24, 2025Revolution Medicines Inca latestage clinical oncology company developing targeted therapies for patients with RASaddicted cancers today announced that the US Food and Drug Administration FDA has granted Breakthrough
Libertas Bio, a Formation Bio subsidiary, License of Gusacitinib, a Dual JAK/SYK Inhibitor, to Sanofi
Tuesday, June 24, 2025Formation Bio an AInative pharma company focused on accelerating drug development today announced that its subsidiary Libertas Bio has licensed gusacitinib an oral dual JAKSYK inhibitor to Sanofi Sanofi will explore its potential in a new indication...
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Tuesday, June 24, 2025Illumina Inc announced today it has entered into a definitive agreement with Standard BioTools NASDAQ LAB under which Illumina will acquire SomaLogic a leader in datadriven proteomics technology and other specified assets for million in cash payable...
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Colorectal Cancer
Monday, June 23, 2025Exelixis Inctoday announced positive topline results from the STELLAR phase pivotal trial in which zanzalintinib in combination with atezolizumab Tecentriq demonstrated a statistically significant
QUVIVIQ® - The World’s New Generation Anti-Insomnia Drug – Approved for Launch，Significantly Improves Sleep and Daytime Functioning
Monday, June 23, 2025Simcere Pharmaceutical HK announced that QUVIVIQ generic name Daridorexant Hydrochloride Tablets an antiinsomnia drug developed in collaboration with Idorsia in Switzerland
XtalPi Announces Strategic Collaboration with Harvard Professor Gregory Verdine's DoveTree LLC to Advance Novel Therapeutics Using AI+Robotics Drug Discovery Platform
Monday, June 23, 2025XtalPi a global leader in AI and roboticspowered drug and materials discovery today announced it has signed a Letter of Intent LOI with DoveTree LLC founded by Harvard University Professor and renowned biopharma
Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors
Saturday, June 21, 2025Ipsen announced today that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has issued a positive opinion for Cabometyx cabozantinib for adult patients with unresectable or metastatic
Everest Medicines Announces Successful Release of First Clinical Batch of Tumor-Associated Antigen Vaccine EVM14 at Jiashan Manufacturing Site
Saturday, June 21, 2025Everest Medicinesa biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced the successful release of the first clinical batch of EVM
